Speech-Language Pathologists in Wintersville, OH Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Alexis R. Watkins Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 250 Cadiz Rd, Wintersville, OH 43953 Phone: 740-264-5245 |
Tina Marie Pearce, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 587 Bantam Ridge Rd, Wintersville, OH 43953 Phone: 740-266-2912 |
Taylor Hawthorne, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 Main St, Wintersville, OH 43953 Phone: 740-275-7166 |
 Hometown Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 875 Main St, Wintersville, OH 43953 Phone: 740-275-7166 |
Vanessa Maurer, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 875 Main St, Wintersville, OH 43953 Phone: 740-769-7395 Fax: 304-243-5880 |
News Archive
Compound of milk thistle shows anti-cancer effects
Recently, scientists demonstrated the anti-cancer effects of silibinin, a major biologically active compound of milk thistle. Being widely used as a folk remedy for liver diseases, milk thistle is safe and well-tolerated, and it protects the liver from drug or alcohol-related injury.
Underwriters exercise overallotment option to purchase additional 480,000 shares in Pharmasset offering
Pharmasset, Inc. announced today the underwriters of its recent stock offering have exercised their option to purchase an additional 480,000 shares of common stock. The net proceeds to Pharmasset, Inc., after deducting the underwriting discount, from the sale of these additional shares are expected to be approximately $13.2 million.
IBM, Siemens Healthineers form global strategic alliance to help providers deliver value-based healthcare
IBM and Siemens Healthineers today announced a five year, global strategic alliance in Population Health Management (PHM).
Johnson & Johnson seeking U.S. approval for first new TB drug in more than 4 decades
"Johnson & Johnson [J&J] said Monday that it is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis [TB] in more than four decades," the Associated Press reports, adding, "The experimental drug, called bedaquiline, also would be the first medicine specifically for treating multi-drug resistant tuberculosis."
New nonsurgical approach to treat chronic pain and stiffness linked with knee osteoarthritis
A new nonsurgical approach to treating chronic pain and stiffness associated with knee osteoarthritis has demonstrated significant, lasting improvement in knee pain, function, and stiffness.
› Verified 1 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Podiatrists
Occupational Therapists
Audiologists